Paul Tudor Jones Ardelyx, Inc. Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Ardelyx, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 130,811 shares of ARDX stock, worth $520,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,811
Previous 126,530
3.38%
Holding current value
$520,627
Previous $654,000
1.83%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ARDX
# of Institutions
235Shares Held
166MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$99.4 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$69.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$59.7 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$44.4 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$40.5 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $615M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...